Table 2.
Variable Importance (VIMP) for important features used to classify each definition of diagnostic groups for the all factors classification scenario; cells are shaded darker for larger VIMP.
| All | CSF | Plasma | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Accuracy: | 77.8% | 88.2% | 68.6% | 75.0% | 88.2% | 66.7% | 55.6% | 72.5% | 47.1% |
| Feature | SIVD vs. AD | SIVD vs. AD and Mixed | SIVD vs. Mixed vs. AD | SIVD vs. AD | SIVD vs. AD and Mixed | SIVD vs. Mixed vs. AD | SIVD vs. AD | SIVD vs. AD and Mixed | SIVD vs. Mixed vs. AD |
| Age at baseline | 0.3% | −0.1% | 2.8% | 0.5% | 2.6% | ||||
| CSF A Beta 42/40 ratio | 1.0% | 1.2% | 1.4% | 1.4% | |||||
| CSF P-Tau | 3.3% | 2.9% | 2.3% | 4.0% | 4.0% | 2.8% | |||
| CSF MSD MMP-9 | 0.4% | ||||||||
| CSF MSD MMP-10 | 3.4% | 5.3% | 4.6% | 4.9% | 6.8% | 5.6% | |||
| Plasma MSD MMP-1 | 1.4% | 1.3% | 0.8% | 4.3% | 3.0% | 1.8% | |||
| Plasma MSD MMP-2 | 1.0% | 0.5% | −0.4% | ||||||
| Plasma MSD MMP-3 | 0.2% | 0.1% | 0.5% | 0.7% | |||||
| Plasma MSD MMP-10 | 0.2% | 2.3% | 1.2% | 0.5% | |||||
| CSF VEGF-A | 0.3% | 0.5% | |||||||
| CSF VEGF-C | 4.3% | 0.7% | 3.1% | 3.4% | 1.1% | 3.8% | |||
| CSF Tie-2 | 1.1% | 0.4% | 0.5% | 0.6% | 0.8% | ||||
| CSF PlGF | 0.0% | 1.8% | 0.4% | 1.8% | |||||
| Plasma Tie-2 | 5.2% | −0.3% | 1.6% | ||||||
| Plasma bFGF | 0.4% | ||||||||
| CSF IL-1B | 0.1% | 0.0% | −0.1% | 0.2% | 0.6% | −0.1% | |||
| CSF IL-2 | 0.7% | 0.5% | 1.6% | 1.2% | 0.7% | ||||
| CSF IL-12p70 | 0.4% | ||||||||
| CSF IL-13 | 1.6% | 0.4% | 0.7% | 0.4% | |||||
| CSF TNF-a | 0.1% | 0.4% | −0.1% | ||||||
| Plasma IFN-g | 0.7% | ||||||||
| Plasma IL-6 | 0.6% | −0.1% | 0.3% | 0.0% | 0.9% | ||||
| Plasma IL-10 | 0.3% | ||||||||
| Plasma IL-13 | 0.4% | 0.3% | 0.7% | 1.5% | |||||